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Abstract. Modern wound dressings combine medical textiles with active compounds that 
stimulate wound healing while protecting against infection. Electrospun wound dressings have 
been extensively studied and the electrospinning technique recognized as an efficient approach 
for the production of nanoscale fibrous mats. The unique diverse function and architecture of 
antimicrobial peptides (AMPs) has attracted considerable attention as a tool for the design of 
new anti-infective drugs. Functionalizing electrospun wound dressings with these AMPs is 
nowadays being researched. In the present work, we explore these new systems by highlighting 
the most important characteristics of electropsun wound dressings, revealing the importance of 
AMPs to wound healing, and the methods available to functionalize the electrospun mats with 
these molecules. The combined therapeutic potential of collagen type I and these AMP 
functionalized dressings will be highlighted as well; the significance of these new strategies for 
the future of wound healing will be clarified.   
1.  Introduction 
Wound dressing design and fabrication are important segments of the textile medical and 
pharmaceutical wound care market worldwide. In the past, traditional dressings were used to simply 
manage the wound, to keep it dry and prevent bacterial entrance. Nowadays, the fabrication of wound 
dressings aims to create an optimal environment that accelerates wound healing, while promoting 
oxygen exchange and intensively preventing microbial colonization [1].  
Electrospinning has become one of the most popular processes to produce medical textiles in the 
form of wound dressings. This is a simple and effective method to produce nanoscale fibrous mats 
with controlled pore size and structure, from both natural and synthetic origin polymers. This 
technique has gain much attention because of its versatility, reproducibility, volume-to-surface ratio 
and submicron range [2-4]. Recently, functionalizing these electrospun wound dressings with active 
compounds that accelerate wound healing and tissue regeneration has become the major goal [5]. The 
rising of antibiotic-resistant infection agents has increased the need for such therapies. While 
antibiotics act selectively against bacteria, dressings functionalized with antimicrobial peptides 
(AMPs) act at multiple sites within microbial cells, reducing the likelihood of bacteria to develop 
resistance [6]. The combination of collagen type I (Col I), one of the most important extracellular 
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matrix (ECM) proteins to wound healing, with these AMP-polymer mat systems has yet to be 
investigated. Col I has been highlighted as uniquely suited for wound dressing therapies because of its 
involvement in all phases of wound-healing [7]. Thus the combination of Col I with the AMPs would 
represent a new step further in the optimization/development of new generation wound dressings.  
In the present paper, we reviewed the basic concepts associated with electrospinning technique and 
explored the use of AMPs in wound healing. Further, we established AMPs functionalization methods 
and highlighted the importance of Col I to tissue regeneration. 
 
2.  Electrospun Wound Dressings  
Electrospinning is a cost-effective, simple and straightforward technique, that allows the production of 
continuous nanofibers with specific properties. Modern dressings are design to facilitate wound 
healing, protect the wounded site from repeated trauma and prevent infection. It has been established 
that the ideal dressing should be haemostatic, absorb exudates, maintain moisture balance, protect 
against pathogens, adapt to the wounded site, cause no pain and be low cost [2-4]. Nanofibrous mats 
produced by eletrospinning may accommodate all these demands.  
2.1.  Technique: Principles 
Electrospinning is based on the principle that strong mutual electrical repulsive forces overcome 
weaker forces of surface tension in the charged polymer liquid. It is capable of consistently produce 
fibers in the submicron range, from 2 nm to several micrometers, with extremely high surface-to-
volume ratio, tunable porosity and malleability. The equipment consists of a syringe needle connected 
to a high DC voltage source of tens of kVs that generates an electrical field with the collecting plate 
and impels the polymer solution to extrude. As it is released, the polymer solution jet becomes 
unstable and elongates, subdividing geometrically into nanofiber jets that are collected at an optimal 
distance. At the same time, the volatile organic solvent used to prepare the polymer solution 
evaporates. In the end, a mat composed of individual continuous nanofibers is obtained [2-4].  
The mat's topography, morphology and fiber orientation are defined by the operating conditions 
(applied voltage, flow rate, distance to collector), solution properties (polymer concentration, 
viscosity, solvent volatility, surface tension, conductivity) and environment conditions (temperature, 
humidity) [8]. By modifying and adapting these parameters to fit our wounds demands, multiple 
distinct nanofibrous medical textiles can be produced.   
2.2.  Natural and Synthetic Polymers for Wound Dressings 
Natural polymers, which derive from renewable sources, are widely used in medicine regenerative 
because of their intrinsically bioactive and biodegradable properties and similarity to the ECM. 
Between the many, polysaccharides, including cellulose, hyaluronic acid, chitin, chitosan, alginates, 
etc., are the most extensively used to manage and treat wounds. Cellulose is perhaps the most used as 
it is an abundant polysaccharide based on glucose of particular interest to wound healing due to its 
flexibility, unique nanostructure and remarkable physical-chemical properties, biocompatibility, 
biodegradability, hydration capacity and antimicrobial features [9].  
Many formulations of individual or blends of synthetic polymers have been investigated for the 
production of dressings with successful results, including poly(ɛ-caprolactone) (PCL), polyurethane 
(PU) and poly(vinyl alcohol) (PVA). PCL is bioresorbable and biocompatible and has been applied for 
the production of wound dressing since the 1970s [10]. PU is a biodegradable hydrophobic polymer 
with excellent mechanical properties, high elongation capacity, good abrasion resistance, high 
flexibility and hardness, and blood compatibility [11]. As a biodegradable, non-toxic or carcinogenic, 
biocompatible polymer with good mechanical properties, PVA is desirable for wound healing due to 
its flexibility and swelling capacity in aqueous environments [12]. 
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3.  Antimicrobial Peptides 
From a microbiological point of view, the primary function of intact skin is to prevent invasion and 
colonization of potential pathogens. Exposure of subcutaneous tissue, following loss of skin integrity, 
provides a moist, warm, and nutritious environment for microorganisms to colonize and proliferate. To 
fight these infections, multicellular organisms have evolved and develop an arsenal of host-defense 
molecules, the AMPs. These natural and synthetic peptides provide a non-specific defense against a 
broad spectrum of invaders, such as bacteria, fungi, and certain viruses, acting like a component of 
innate immunity [5]. 
AMPs are low molecular weight molecules composed of 5 to 100 amino acid residues. AMPs are 
often cationic due to the excess of lysine, arginine and histidine amino acids, and most AMPs are 
amphipatic, containing both hydrophilic and hydrophobic amino acid residues organized in a helical 
molecule. The amphipatic helical structure is most effective interacting with biomembranes, since it 
endows the AMPs with the capacity to bind to lipid components (hydrophobic regions) and 
phospholipid groups (hydrophilic regions) [13]. AMPs can be subdivided in four main classes, 
according to its structural diversity: α-helix, β-sheet, extended and loop. The α-helix and β-sheet 
configurations are the most common; the first is formed only when the peptide contacts with a 
membrane, and the second is stabilized by 2 to 4 disulfide bonds. The less common, extended and 
loop, display a curved form in response to a simple disulfide bond or the presence of proline residues 
in its structure. AMPs can also be classified based on their target microorganism: antibacterial 
peptides (most common), which target the cell membranes disintegrating the lipid bilayer structure; 
antiviral peptides, which neutralize the viruses by integrating in either the viral envelope or the host 
cell membrane; antifungal peptides, which kill by targeting either the cell wall or the intracellular 
components; and antiparasitic peptides, which kill by direct interaction with the cell membrane [6].  
3.1.  AMPs in Wound Healing 
AMPs are found in a variety of tissues. They were first observed in mammalian skin in the form of 
cathelicidin PR-39 [14]. Later, human cathelicidin hCAP-18 was detected in epidermal keratinocytes. 
Since then, many others, like the human defensin hBD-3, were studied and cloned for wound healing 
purposes [15].  
The hCAP-18 is the only human cathelicidin. It is found in specific granules of neutrophils, in 
keratinocytes during skin inflammation or even in the lungs. Plasma contains, as well, a high 
concentration of hCAP-18 bound to lipoproteins. The LL-37, which is the antibacterial C-terminus of 
hCAP-18, displays broad antimicrobial activity against both Gram-positive and Gram-negative 
bacteria, has synergistic antibacterial effects with defensins, and is a potent chemoattractant agent for 
neuthophils, monocytes and T cells. LL-37 has been shown to be up-regulated in the skin following 
injury and, thus, to increase its sensibility towards infection [16,17]. The human β-defensin-3 or hBD-
3 possesses a broad bactericidal activity against both Gram-positive and Gram-negative bacteria, and 
has also been associated with increased cytokine secretion and keratinocytes expression, cell migration 
and proliferation, enhanced anti-inflammatory activity, and accelerated wound closure [18]. 
Aside from human-derived AMPs, there are others from amphibian, vertebrate, insect or pathogen 
origins that have revealed great results as wound healing promoters. The isolation of magainins from 
Xenopus laevis species led to the discovery of a wide range of amphibian peptides of great potential. 
Pexiganan, for instance, was one of the first AMPs to be synthesized from mangainin. It is mainly 
applied in the treatment of infected wounds, including diabetic ulcers, and has been shown to reduce 
microbial burden. Pexiganan is also known to stimulate migration of cells involved in tissue 
reconstruction [19].  
3.2.  AMPs Functionalization 
Following concerns over the development and spread of antibiotic-resistant strains of bacteria, the use 
of dressings that combine AMPs with well-established biomedical polymers has increased. 
Functionalizing AMPs onto electrospun dressings has become a most important process [20].  
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There are many strategies used to immobilize AMPs onto electrospun dressings. The most common 
and simplest is the co-spinning method. Here, AMPs are immobilized as the polymeric nanofibers are 
produced. Multifunctional bioactive nanofibrous dressings, with an all-in-one approach, are therefore 
the result of co-spinning [21]. Physical adsorption methods, which include adsorption and layer-by-
layer assembly, involve physisorption of AMPs through non-covalent or multidentate interactions at 
the electrospun surface. Adsorption is the most straightforward approach. It requires only the 
immersion of the electrospun mats in a solution containing the selected AMPs, for the time required to 
reach saturation. This method, however simple, is most challenging without using binding agents, as 
quick desorption of the AMPs in response to mechanical forces remains a complication. In the layer-
by-layer approach, AMPs are sandwiched between two polyionic polymers. Using this method a 
flexible number of layers with controlled AMP loading can be prepared by exchanging electrospun 
solutions at the appropriate time. As a downside, the AMPs immobilized in between layers may have 
more difficulties to diffuse towards the wounded site [22].  
Compared to physical immobilization, covalent binding offers many more advantages, including 
minimizing AMPs leaching, providing long-term stability and lowering toxicity. It can be 
accomplished by two ways: "graft to" approach, which involves the covalent coupling of the intact 
AMPs to the electrospun surface; or "surface initiated" strategy, which requires the synthesis of the 
AMPs from initiators or spacers bearing reactive groups covalently immobilized onto the mat's 
surface. "Graft to" strategies entail the activation of the electrospun surfaces to generate free binding 
groups like amines, carboxylic acids, aldehydes or thiols. More often than expected, the linkage 
between these free functional groups and the AMPs may be hydrolyzed or broken by mechanical 
forces, even though the covalent bonds created are strong and irreversible [20]. Polymer resins like 
polyethylene glycol (PEG) are frequently functionalized onto electrospun dressings to induce "surface 
initiated" immobilization. As a linker, PEG aside from reducing bacteria interactions also allows rapid 
and free orientation of the bound AMPs at the interface, thus enhancing the protective performance of 
the bound AMPs and its action mode [23].  
4.  Collagen Type I in Wound Healing 
Collagen is an extremely important ECM protein, majorly present in the connective tissues (i.e. 
tendons, bone, skin, etc.). 25-35% of the total amount of proteins in the human body are collagen and, 
from the 16 existing types, Col I is the most common, representing near 90% of the organic mass of 
bone [24]. Col I has an excellent biocompatibility, which makes it popular in artificial tissue and 
wound dressings manufacture. The native fibrillar collagen is the most important polymorphic form of 
collagen, which makes manufacture of fibrous dressing products possible [25]. In the form of wound 
dressings, Col stimulates the wound healing cellular and molecular cascades, development of new 
tissues and wound debridement [26]. In fact, Col I has been highlighted as uniquely suited for wound 
dressing therapies because of its involvement in all phases of wound-healing. Platelets aggregate 
around exposed collagen and secrete factors that stimulate the intrinsic clotting cascade responsible for 
a stable hemostatic "plug". Further, collagen-based wound dressings have been shown to address the 
issue of elevated levels of matrix metalloproteinases, a key component of chronic wounds known to 
degrade non-viable and viable collagen, by acting as "sacrificial substrates" in the wound [7]. Collagen 
fibrils have been combined with other polymeric matrixes to produce dressings with the ability to 
absorb wound exudates to maintain a moist environment and, thus, stimulate wound healing [27,28]. 
5.  Conclusions and Future Perspectives 
Due to the continue rising of antimicrobial resistant pathogens, the need for engineered alternated 
treatments for acute to chronic wound care has increased. As a first strategy to overcome this issue, 
AMPs have been loaded onto existing textile medical dressings to improve their healing and 
antimicrobial capacities. We highlighted the most well known AMPs and the most appropriate 
methods to functionalize the surface of electrospun mats with such molecules. This is still a very new 
formulation and further research should be conducted. Indeed, long-term therapeutics using AMPs 
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functionalized dressings should be carefully evaluated to prevent the risk of compromising our innate 
immune defense and, therefore, the ability to control commensal microbiome and microbial infections. 
Functionalizing surfaces with AMPs should be managed by standardized tests that not only evaluate 
the action of the AMPs but as well its stability, releasing abilities and tunable performance. The level 
of control in peptide loading and release timescales that are required in applications that could benefit 
from such antimicrobial profile has thus far not been demonstrated. Because they are still being 
developed and tested, these systems, AMPs-polymeric mat, should be cautiously defined so that the 
best combination between selected polymer, mechanism of action, AMPs and immobilization process 
is achieved. Although Col I has been extensively used in wound healing and its potential already 
demonstrated, the combination with AMPs-polymeric mats systems has yet to be explored. In a near 
future, we intend to examine the synergistic performance of these molecules in the treatment of 
chronic wounds, namely diabetic ulcers. We are confident these new systems aside from acting against 
the pathogens will also accelerate the wound healing process by establishing a symbiotic action.  
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